Frontiers in Pharmacology | Respiratory Pharmacology

Case Report

Published on 08 Jul 2026

Case Report: When access is limited: using CYP3A4 inhibition to maintain clinical benefit from elexacaftor/tezacaftor/ivacaftor

in Respiratory Pharmacology

Keirran Hiscock
Michelle Wood
Ellie Johnson
Daniel Smith
Ieuan E. S. Evans

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1877957

240 views

Original Research

Accepted on 06 Jul 2026

The impact of patient age on the pharmacist's recommendation of OTC anti-common cold products before and during COVID-19 pandemic

in Respiratory Pharmacology

Paulina Natalia Kopa-Stojak
Malgorzata Pietrusiewicz
Rafał Pawliczak

Frontiers in Pharmacology

Systematic Review

Published on 02 Jul 2026

Long-term efficacy of traditional Chinese medicine combined with chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of reconstructed individual patient data over 3 years

in Respiratory Pharmacology

Yixuan Guo
Dan Wang
Xuexiu Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1818515

697 views

Review

Accepted on 30 Jun 2026

Exploring the Therapeutic Landscape of Pulmonary Hypertension Associated with Interstitial Lung Disease, with a focus on Idiopathic Pulmonary Fibrosis: a Narrative Review

in Respiratory Pharmacology

Nicolò Reccardini
Beatrice Da Re
Lucrezia Mondini
Francesco Salton
MARCO CONFALONIERI
Paola Confalonieri
Michael Hughes
Giorgio Monteleone
Barbara Ruaro

Frontiers in Pharmacology

168 views

Case Report

Accepted on 25 Jun 2026

Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: A case report

in Respiratory Pharmacology

Ailifeila Aili
Hui Deng
Haopeng Zhang
Weiwei Wang
Lei Pan

Frontiers in Pharmacology

180 views

Original Research

Published on 25 Jun 2026

Association between dexmedetomidine administration and 28-day mortality in critically ill patients with ventilator-associated pneumonia

in Respiratory Pharmacology

Songmei Guan
Congcong Lv
Shigang Duan
Jianmin Qu
Tingting Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1785115

550 views

Original Research

Published on 24 Jun 2026

Qingre–Huatan–Liqi formula attenuates FPM-induced lung injury via modulation of MAPK signaling and NETs formation

in Respiratory Pharmacology

Jie Yang
Yaqian Liu
Yufeng Meng
Hongtao Wang
Xianqiang Zhou
Xuyi Zhao
Cuiling Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1778590

515 views

Original Research

Published on 24 Jun 2026

The CHRNA5 rs16969968 variant is associated with MMP-9 expression and inflammatory signaling in COPD in a West Bengal population, India

in Respiratory Pharmacology

Himani Adhikari
Nasima Sultana
Achintya Mohan Goswami
Indranil Ganai
Himani Biswas
Amalesh Mondal
Asif Iqbal
Saibal Moitra
Sanjoy Podder

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1841945

549 views

Original Research

Published on 19 Jun 2026

Targeting PTP4A3 with KVX-053 mitigates alcohol-amplified SARS-CoV-2 spike protein–induced acute lung injury

in Respiratory Pharmacology

Pavel A. Solopov
Ruben Manuel Luciano Colunga Biancatelli
Elizabeth R. Sharlow
John S. Lazo
John D. Catravas

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1862783

770 views

Original Research

Accepted on 18 Jun 2026

Mechanistic Investigation of Midkine-Notch2 Signaling in Suppressing Pulmonary Artery Smooth Muscle Cell Apoptosis and Promoting Vascular Remodeling in Hypoxic Pulmonary Hypertension

in Respiratory Pharmacology

Houfan Zhu
Xunkai Wang
Lin Huang
Jin Peng
Jiangpeng Wu
Yong Liao
Shengchao Wei
Shijie Zhong
Guiyun Jin
Tang Deng

Frontiers in Pharmacology

228 views

Original Research

Published on 15 Jun 2026

Hylocereus undatus flower inhibits lipopolysaccharide-induced acute lung injury in mice by regulating the gut-lung axis and inflammatory response

in Respiratory Pharmacology

Shujie Fu
Wanzhong Liao
Bizuan He
Huafeng Wu
Jing Huang
Weizhe Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1803336

1,619 views

Original Research

Published on 15 Jun 2026

RANKL–RANK signaling promotes cigarette smoke–induced emphysema with MMP-9 upregulation in alveolar macrophages

in Respiratory Pharmacology

Lu Zhou
Baiquan Zhang
Huanqin Wang
Fengxiang Huang
Lijun Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1754836

698 views

Original Research

Published on 11 Jun 2026

Polydopamine–polyethylene glycol–liproxstatin-1 nanoparticles inhibit ferroptosis for enhanced treatment of neutrophilic asthma

in Respiratory Pharmacology

Chen Bao
Decai Wang
Chao Liu
Meizhou Zhang
Qian Liu
Jiannan Hu
Yuzhou Wu
Shuyun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1809896

712 views

Original Research

Published on 10 Jun 2026

SPP1 and MMP1 as key therapeutic targets of Jingfang Granule in idiopathic pulmonary fibrosis: integrated bioinformatics and machine learning analysis

in Respiratory Pharmacology

Yifan Ren
Jingzhe Gao
Kunshuang Shen
Shan Jiang
Yaoyu Xie
Yuanyuan Wang
Xiaoran Sun
Yaoai Wang
Ning Zhang
Siju Lou

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1739181

1,437 views

Case Report

Published on 09 Jun 2026

Case Report: Is it COPD? It is Fabry disease: a case in which bronchodilators were briefly used but not continued, prioritizing enzyme replacement therapy

in Respiratory Pharmacology

Yanyan Li
Hongyi Zhu
Zijie Zhan
Ge Li
Sulan Huang
Changhui Xiao
Ying Li
Chao Zheng
Fan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1843864

1,193 views

Original Research

Accepted on 03 Jun 2026

Knowledge, Attitudes, and Practices of Primary Care General Practitioners Regarding COPD Inhaler Education: A Cross-sectional Study in Yiwu, China

in Respiratory Pharmacology

Dingjin Lou
Yiming Teng
Jingjing Ren
Zhening Yang
Mingmin Chen

Frontiers in Pharmacology

351 views

Original Research

Accepted on 02 Jun 2026

Risk stratification-based tiered medication therapy management (T-MTM) for outpatients with asthma: a practical prospective study

in Respiratory Pharmacology

Yufei Lian
Shujuan Xiong
Haijing Zhao
Yanru Deng
Huizhen Wu

Frontiers in Pharmacology

305 views

Original Research

Published on 01 Jun 2026

Repurposing ivacaftor to attenuate LPS-induced acute lung injury: evidence from a non-cystic fibrosis model

in Respiratory Pharmacology

Xiaoxuan Han
Yimin Zhu
Christopher W. Armstrong
Danni Li
Rachel McQuade
Andrew Jarnicki
Elena K. Schneider-Futschik

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1787276

1,214 views

Original Research

Published on 20 May 2026

Association between terbutaline sulfate plus ambroxol hydrochloride and clinical outcomes, pulmonary function, and inflammatory biomarkers in elderly patients with acute exacerbation of chronic obstructive pulmonary disease

in Respiratory Pharmacology

Xin Yu
Haiwen Zhou
Jintao Zhu
Nini Zhang
Dexin Wang
Songbiao Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1808041

1,205 views

Case Report

Published on 12 May 2026

The combination of osimertinib and chemotherapy successfully enabled surgical resection of locally advanced lung adenocarcinoma: a Case Report

in Respiratory Pharmacology

Cheng-Yi Lin
Qun-Xian Zhang
Dan Li
Tao Zeng
Jun Zhang
Qiang Guo
Xiang-Yu Luo
Tao Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1695807

1,310 views

Original Research

Published on 11 May 2026

miR-21-5p attenuates hyperoxia-induced lung injury by modulating YAP1-dependent ferroptosis

in Respiratory Pharmacology

Qianxia Huang
Ping Yuan
GuoYue Liu
Guiyang Jia
Erqin Song
Kangjie Qin
Zhihui Wang
Fengmin Yin
Miao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1804152

1,048 views

Original Research

Published on 08 May 2026

Glucocorticoids injure the airway epithelial barrier via endoplasmic reticulum stress-related apoptosis in asthma

in Respiratory Pharmacology

Hao You
Wenjing Zou
Kunpeng Wang
Tangqiaochu Gan
Jie Hu
Wen Tan
Ting Wang
Luo Ren
Gang Geng
Zhou Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1771751

1,194 views

Review

Published on 07 May 2026

EV-associated non-coding RNAs in paediatric asthma airway remodelling: current mechanistic evidence and therapeutic perspectives

in Respiratory Pharmacology

Yaling Liu
Dan Wang
Hu Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1820574

1,260 views

Original Research

Published on 04 May 2026

Oral losartan yields subtherapeutic airway exposure compared to nebulized delivery and fails to improve mucociliary clearance in cystic fibrosis

in Respiratory Pharmacology

Charles D. Bengtson
Andreas Schmid
Michael D. Kim
John S. Dennis
J. Steven Leeder
Kirby L. Zeman
William D. Bennett
Juan Sabater
Nathalie Baumlin
Matthias Salathe

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1807581

1,122 views